Physician and patient perception of adjustable maintenance dosing of Symbicort Turbuhaler - REALITY

Study identifier:D5890L00021

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Physician and patient perception of adjustable maintenance dosing of Symbicort Turbuhaler

Medical condition

perception of physicians & patients of AMD

Phase

-

Healthy volunteers

No

Study drug

Symbicort

Sex

All

Actual Enrollment

217

Study type

Observational

Age

12 Years +

Date

Study Start Date: 01 Sept 2006
Primary Completion Date: -
Study Completion Date: 01 Aug 2007

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria